Sort   by:  
 Page size 
UnknownSARS-CoV-2 antibody responses in patients with acute leukaemia.
Not available
S-EPMC7724438 | biostudies-literature
UnknownNeutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection.
Not available
S-EPMC8081267 | biostudies-literature
UnknownDefining Potential Therapeutic Targets in Coronavirus Disease 2019: A Cross-Sectional Analysis of a Single-Center Cohort.
Not available
S-EPMC8352605 | biostudies-literature
UnknownSex differences in immunological responses to COVID-19: a cross-sectional analysis of a single-centre cohort.
Not available
S-EPMC8156911 | biostudies-literature
UnknownHigh affinity mAb infusion can enhance maximum affinity maturation during HIV Env immunization.
Not available
S-EPMC10973984 | biostudies-literature
UnknownSARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies.
Not available
S-EPMC8759779 | biostudies-literature
UnknownFailure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV.
Not available
S-EPMC8169058 | biostudies-literature
UnknownPreservation of memory B cell homeostasis in an individual producing broadly neutralising antibodies against HIV-1.
Not available
S-EPMC10871235 | biostudies-literature
UnknownThe effect of spike mutations on SARS-CoV-2 neutralization.
Not available
S-EPMC7936541 | biostudies-literature
UnknownNatural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1.
Not available
S-EPMC10624865 | biostudies-literature
Sort   by:  
 Page size